Pathfinder Cell Therapy (Pathfinder Cell Therapy) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Pathfinder Cell Therapy's long-term debt to total assests ratio for the quarter that ended in Sep. 2015 was 0.00.

Pathfinder Cell Therapy's long-term debt to total assets ratio stayed the same from Sep. 2014 (0.00) to Sep. 2015 (0.00).

Pathfinder Cell Therapy LT-Debt-to-Total-Asset Historical Data

The historical data trend for Pathfinder Cell Therapy's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy LT-Debt-to-Total-Asset Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Pathfinder Cell Therapy LT-Debt-to-Total-Asset Calculation

Pathfinder Cell Therapy's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2014 is calculated as

LT Debt to Total Assets (A: Dec. 2014 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2014 )	/	Total Assets (A: Dec. 2014 )
	=	0	/	0.106
	=

Pathfinder Cell Therapy's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2015 is calculated as

LT Debt to Total Assets (Q: Sep. 2015 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2015 )	/	Total Assets (Q: Sep. 2015 )
	=	0	/	0.039
	=

Pathfinder Cell Therapy (OTCPK:PFND) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Pathfinder Cell Therapy LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines